Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Symposia

Somatostatin receptors in pituitary

ea0029s65.1 | Somatostatin receptors in pituitary | ICEECE2012

Imaging somatostatin activity in live pituitary

Schulz S.

Fluorescence resonance energy transfer (FRET) using genetically encoded biosensors has proven to be a powerful technique to monitor the spatiotemporal dynamics of cAMP signals stimulated by Gs-coupled receptors in living cells. In contrast, real-time imaging of Gi-mediated cAMP signals under native conditions remains challenging. Here, we describe the use of transgenic mice ubiquitously expressing the highly sensitive cAMP sensor Epac1-camps for cAMP imaging in living pituitar...

ea0029s65.2 | Somatostatin receptors in pituitary | ICEECE2012

Is somatostatin receptor expression in adenomas related to pharmacological response?

Fougner S.

The clinical response to somatostatin analogue (SMS) treatment in acromegaly is highly variable. In unselected, previously untreated patients, biochemical control is achieved in 20–50% of patients, and mean overall tumour shrinkage has been reported to 25–40%.The somatostatin analogues exert their effects through binding to the somatostatin receptor (SSTR) localized in the cell membrane. The available analogues bind with high affinity to SSTR2,...

ea0029s65.3 | Somatostatin receptors in pituitary | ICEECE2012

Somatostatin receptors and filamin: a developing story

Najib S. , Saint-Laurent N. , Fourmy D. , Schulz S. , Luque R. , Castano J. , Delisle M. , Pyronnet S. , Susini C. , Bousquet C.

The G protein-coupled (GPCR) somatostatin receptor sst2 transduces the majority of somatostatin actions, including inhibition of hormone and growth factor secretion, cell survival and angiogenesis. Sst2 agonists such as octreotide are widely used for the treatment and diagnostic of human neuroendocrine tumors that frequently over-express sst2. To initiate its inhibitory signalling pathways, sst2 engages, in addition to G protein subunits, different protein partners such as pho...